Mechanistically, the dual function antibody targeting avβ3 and PD-L1 enhances tumor growth suppression, through increased infiltration of cytotoxic CD8+ T cells and reduced intratumoral microvessel density (Figure 7). The gene discussed is CD8A; the disease is neoplasm.